From The Source
- Imugene: Two Additional Complete Responses and Three Partial Responses in azer-cel CAR T Phase 1b trial
- APRA consults on minor updates to Health Benefits Fund Enforcement Rules 2015
- DoHDA: A clearer rural pathway for non-GP specialists
- Indigenous midwife referred to by racist slur on staff whiteboard at Sydney’s RPA hospital
- Prevention the best form of diabetes treatment: RACGP – Royal Australian College of GPs
- Global, regional, and national health-care inefficiency and associated factors in 201 countries, 1995–2022: a stochastic frontier meta-analysis for the Global Burden of Disease Study 2023
- COVID-19 outbreaks in Australian residential aged care homes – 11 July 2025
- Olympic/Paralympic heroes join medical experts urging parents and young adults to “be vigilant” with meningococcal cases expected to climb this peak season – GSK
- Physical Disability Australia to host “Fair and Accessible Healthcare” webinar on 5th August – Physical Disability Australia (PDA)
- Office of the Commonwealth Ombudsman: Quarterly Update: 1 January to 31 March 2025
- Harnessing mRNA to prevent and slow Alzheimer’s disease – The Florey
- Amplia Therapeutics: Another partial response confirmed in Accent pancreatic cancer trial
